Spautin-1 inhibits the growth of diffuse large B-cell lymphoma by inducing mitochondrial damage-mediated PANoptosis and anti-tumor immunity
Abstract The prognosis of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is poor. Therefore, searching for new therapeutic agents is particularly important to improve therapeutic efficacy. Targeting the ubiquitin-proteasome system is a potential therapeutic strategy for treating DLBCL....
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer
2025-08-01
|
| Serie: | Cancer Immunology, Immunotherapy |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1007/s00262-025-04150-9 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|